Your Article Summary
Quality Control of Flow Cytometry Data Analysis for Evaluation of Minimal Residual Disease in Bone Marrow From Acute Leukemia Patients During Treatment
Journal of Pediatric Hematology/Oncology, 07/01/09
Bjorklund E et al. - The continuing standardization resulted in better concordance in QC3 and QC4 compared with QC1 and QC2. The concordance was higher in precursor B as compared with T-cell ALL. The authors conclude that after standardization, flow cytometry MRD detection can be reliably applied in international, multicenter treatment protocols.
Related Articles
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09
Relevance Score: 69%
Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09
Relevance Score: 68%
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Current Opinion in Oncology, 10/14/09
Relevance Score: 68%
FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09
Relevance Score: 68%
Unrelated Hematopoietic Stem Cell Transplantation for Children with Acute Leukemia: Experience at a Single Institution
Journal of Korean Medical Science, 10/05/09
Relevance Score: 68%
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Distinct features of colorectal cancer in children and adolescents
Cancer, 12/15/09
Neurofibromatosis type 1 and high-grade tumors of the central nervous system
Child's Nervous System, 12/15/09
Aggressive fibromatosis in children and adolescents
Cancer, 12/15/09

See Latest Articles